Properties
Description
Remibrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Formula
C27H27F2N5O3
Identity
Confirmed by NMR/HPLC/MS.
Applications
Remibrutinib is investigated for its potential in modulating immune responses through BTK inhibition, relevant for autoimmune conditions.
